December 15, 2016
FDA nods to Pfizer’s skin disease drug
U.S. Food and Drug Administration (FDA) has approved Pfizer’s Eucrisa (crisaborole) ointment 2%, a novel non-steroidal topical phosphodieterase-4 (PDE-4) inhibitor…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Albert Bourla